Topper David Joseph 4
4 · Arcutis Biotherapeutics, Inc. · Filed Mar 4, 2025
Insider Transaction Report
Form 4
Topper David Joseph
Chief Financial Officer
Transactions
- Award
Common Stock
2025-02-28+34,000→ 192,374 total - Award
Stock Option (right to buy)
2025-02-28+89,000→ 89,000 totalExercise: $13.69Exp: 2035-02-28→ Common Stock (89,000 underlying)
Footnotes (2)
- [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting, in which 25% of the RSUs vest annually on March 1, (the "Vesting Commencement Date"), of each year beginning March 1, 2026, subject to the Reporting Person's continued service to the Issuer.
- [F2]1/48th of the shares subject to the option vest on each monthly anniversary measured from March 1, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.